Message #12 From:
Stock News Bot Date: December 6, 2005 03:00:00 AM
CLSN News The Chelsea Collection Inc. Announces Media Launch
LAS VEGAS--(BUSINESS WIRE)--Dec. 6, 2005--G-H-3 International, a wholly owned subsidiary of The Chelsea Collection Inc. (Pink Sheets:CLSN), announced that the Company has launched a major marketing campaign to introduce the exclusive G-H-3 Plus(R) protocol being available in its licensed medical clinic in Florida.
"The company is launching a major marketing campaign that will include top health magazines, antiaging seminars, and airline frequent flyers. We have negotiated several agreements in regards to advertising our services and will be announcing the specifics later this month. This assures that we can offer the G-H-3 Plus(R) protocol, developed by world-renowned geriatric doctor and researcher Dr. Ana Aslan, to the general public. Emerald Hills Medical clinic in Florida is now taking reservations for the treatment. In addition, we are continuing talks with various investors in order to generate the capital necessary to expand the treatment to other clinics. I am personally in the process of taking the treatment and believe that this is the most exciting project of my 30-year-plus career," said Flo Ternes, president and CEO.
This document contains "forward-looking statements" concerning CLSN/G-H-3 International Inc.'s operations and strategies, including its future economic performance, intent, plans, objectives and the likelihood of success in developing and expanding the business. These statements are based upon assumptions and estimates that are subject to significant uncertainties, many of which are beyond G-H-3 International Inc.'s control. Words such as "may," "would," "could," "will," "expect," "anticipate," "intend," "plan," and "estimate" are meant to identify such forward-looking statements. Actual results may differ materially from those expressed or implied by such forward-looking statements. The company assumes no obligation to update this information.
